AOA-backed DOC Access Act gains U.S. Senate companion
Members of the WVAOP pose for photo with Sen. Joe Manchin, D-W.V. , (center, back row) during 2019 AOA on Capitol Hill. Sen. Manchin introduced DOC Access Act in U.S. Senate on Nov. 12.
In a testament to the tireless advocacy of the AOA and its affiliates, the bipartisan Dental and Optometric Care Access (DOC Access) Act now has a new Senate companion.
Introduced on Nov. 12 by Sens. Joe Manchin, D-W.Va., and Kevin Cramer, R-N.D., S. 4894 (the DOC Access Act) aims to put doctors and patients back in control of important health care decisions by ending abusive vision plan practices. The bill, also backed by the American Dental Association, was referred to the Senate’s Committee on Health, where it awaits further consideration.
While the 116th Congress is in its waning days, the introduction of the bill is nevertheless an important milestone in its advocacy and sets up the AOA, affiliates and the ADA for an all-out House-Senate push in the next Congress—convening Jan. 3, 2021. H.R. 3762, the House version of the DOC Access Act, remains active with 63 co-sponsors including nearly a dozen new co-sponsors added since September’s virtual AOA on Capitol Hill.
“This development represents a major progression of the DOC Access Act and is the result of hard work by our profession’s strongest advocates—doctors of optometry and our affiliates, and in particular leaders in West Virginia and North Dakota,” says Ronald L. Benner, O.D., AOA Board of Trustees member and board liaison to the West Virginia Association of Optometric Physicians.
“The AOA and its members, including frontline advocates Dr. Dori Carlson, former AOA president, of North Dakota, and Dr. Laura Suppa, a new AOA Federal Relations Committee member, of West Virginia, have pushed for this bill by communicating consistently to Congress the stories of our member doctors and their patients being challenged by abusive vision plans sold on the federal market,” Dr. Benner adds. “While many states have pursued relief through their state legislatures, we need to have a federal remedy for the plans regulated at the federal level.”
Stopping interference in doctor-patient relationship
The DOC Access Act has been priority legislation of the AOA and affiliates since the 115th Congress when a version was first introduced in the House. This is the first time the DOC Access Act has seen introduction of companion legislation in the Senate.
The bill aims to counter abusive practices in the federally regulated vision and dental coverage markets, and ensure patients and doctors, not insurance and plan executives, are at the center of important health care decision making.
The bill is similar to the House version and remains focused on disallowing detrimental ERISA and other federally regulated plan policies, mainly:
- Limits on a doctor's choice of lab.
- Mandates on noncovered services and materials.
Two of the nation’s most dominant vision plans provide coverage to roughly two-thirds of Americans. Unfortunately, special legal treatment (vision plans often aren't regulated like health insurers) and a lack of competition in the market (the two most dominant vision plans cover roughly two-thirds of Americans with this coverage) mean plans too often insert themselves into doctor-patient decision making.
An Avalon Health Economics report found that this kind of monopsony behavior exhibited by vision plans harms consumers. Avalon concluded that "such mandates have another effect—they lead to higher overall costs for these consumers and, especially, for consumers without vision plans as doctors are forced to compensate for the transfer of operating margins from doctors to the plans."
More than 40 states have enacted legislation addressing vision and/or dental plan abuses; however, up to one-half of plans operating in any given state can sidestep these state laws because they are instead federally regulated.
Educate and act
What can doctors of optometry do to support S.4894?
- Connect with your U.S. senator to explain how current health and vision plan policies negatively impact your patients and practice and urge their support on S4894. Visit AOA's Online Legislative Action Center to learn more and take action.
- Consider investing in AOA-PAC, the only federal political action committee dedicated to fighting and winning for optometry and our patients.
Princeton, New Jersey-based Avalon Health Economics says plans’ mandated discounts for noncovered services and materials—and limits on laboratory freedom—harmfully distort the vision care market for patients and doctors of optometry. To fight back, the AOA is mobilizing its members and other national doctor groups to educate and inform Congress, now and in lead-up to in-person AOA on Capitol Hill.
AOA President calls advocacy a “privilege” to represent the profession and doctors of optometry, as a plethora of issues are tackled in 2021 and beyond.
Lawmakers are demanding a federal study to assess the need for future legislative or regulatory action against DTC prescription medical device sellers, after the AOA and other advocates spent years citing concerns.